Repeated Thrombolysis for Chronologically Separated Ischemic Strokes
نویسندگان
چکیده
منابع مشابه
Repeated thrombolysis for chronologically separated ischemic strokes: a case series.
BACKGROUND AND PURPOSE Recombinant tissue plasminogen activator is used for the treatment of acute myocardial infarction, pulmonary embolism, and acute ischemic stroke. With many years since approval of the drug and an aging population, chances increase that patients are treated twice for chronologically separated events. METHODS We identified patients from the prospective Erlangen Stroke and...
متن کاملIschemic strokes after cardiac catheterization: opportune thrombolysis candidates?
Stroke is an important complication after cardiac catheterization procedures, resulting in death and disability for thousands of patients each year. Common risk factors include advanced age, vascular comorbidities, and more complicated and invasive procedures. Several lines of evidence suggest that these strokes are embolic, from either dislodgement of a clot or atheromatous debris off the aort...
متن کاملIschemic strokes in children.
Ischemic stroke is an uncommon, but significant cause of disability in childhood. Children with strokes present with predictable deficits as adults do; however, fever and seizures at stroke onset are more common in children than in adults. Strokes in children have diverse etiologies and require extensive evaluation. Etiology remains obscure in up to half of the patients. Prognosis in childhood ...
متن کاملIntravenous thrombolysis is more effective in ischemic cardioembolic strokes than in non-cardioembolic?
UNLABELLED It was suggested that intravenous thrombolysis (IT) leads to larger extent recanalization in cardioembolic stroke. In this work we assess if this has beneficial clinical traduction. METHOD We evaluated 177 patients undergoing IT, which were categorized into cardioembolic (CE) and non-cardioembolic (NCE). National Institutes of Health Stroke Scale (NIHSS) and modified Rankin scale w...
متن کاملReply: Intravenous thrombolysis for ischaemic strokes: a call for reappraisal.
Sir, Many thanks for giving us the opportunity to reply to the letter in reference to our review ‘The exact science of stroke thrombolysis and the quiet art of patient selection’ (Balami et al., 2013). Aside from well documented limitations, recombinant tissue plasminogen activator (rt-PA, alteplase) remains the only evidence-based treatment in acute ischaemic stroke (Balami et al., 2013) with ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Stroke
سال: 2010
ISSN: 0039-2499,1524-4628
DOI: 10.1161/strokeaha.110.585067